356 related articles for article (PubMed ID: 22958932)
21. Accelerated wound healing by mTOR activation in genetically defined mouse models.
Squarize CH; Castilho RM; Bugge TH; Gutkind JS
PLoS One; 2010 May; 5(5):e10643. PubMed ID: 20498714
[TBL] [Abstract][Full Text] [Related]
22. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells.
Stokman MA; Spijkervet FK; Wymenga AN; Burlage FR; Timens W; Roodenburg JL; de Vries EG
J Oral Pathol Med; 2002 Mar; 31(3):153-7. PubMed ID: 11903821
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin increases oxidative stress response gene expression in adult stem cells.
Kofman AE; McGraw MR; Payne CJ
Aging (Albany NY); 2012 Apr; 4(4):279-89. PubMed ID: 22529334
[TBL] [Abstract][Full Text] [Related]
24. Rspo1-LGR4 axis in BMSCs protects bone against radiation-induced injury through the mTOR-dependent autophagy pathway.
Chen X; Chen L; Tan J; Zhang L; Xia J; Cheng B; Zhang W
J Cell Physiol; 2021 Jun; 236(6):4273-4289. PubMed ID: 33452710
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells.
Park JH; Lee NK; Lim HJ; Ji ST; Kim YJ; Jang WB; Kim DY; Kang S; Yun J; Ha JS; Kim H; Lee D; Baek SH; Kwon SM
Exp Mol Med; 2020 Apr; 52(4):615-628. PubMed ID: 32273566
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.
Sun ZJ; Zhang L; Hall B; Bian Y; Gutkind JS; Kulkarni AB
Clin Cancer Res; 2012 Oct; 18(19):5304-13. PubMed ID: 22859719
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of IGF-1R prevents ionizing radiation-induced primary endothelial cell senescence.
Panganiban RA; Day RM
PLoS One; 2013; 8(10):e78589. PubMed ID: 24205274
[TBL] [Abstract][Full Text] [Related]
28. Impact on Autophagy and Ultraviolet B Induced Responses of Treatment with the MTOR Inhibitors Rapamycin, Everolimus, Torin 1, and pp242 in Human Keratinocytes.
Xu S; Li L; Li M; Zhang M; Ju M; Chen X; Gu H
Oxid Med Cell Longev; 2017; 2017():5930639. PubMed ID: 28400912
[TBL] [Abstract][Full Text] [Related]
29. Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury.
Sureban SM; May R; Qu D; Chandrakesan P; Weygant N; Ali N; Lightfoot SA; Ding K; Umar S; Schlosser MJ; Houchen CW
PLoS One; 2015; 10(8):e0135561. PubMed ID: 26270561
[TBL] [Abstract][Full Text] [Related]
30. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.
Coppock JD; Vermeer PD; Vermeer DW; Lee KM; Miskimins WK; Spanos WC; Lee JH
Oncotarget; 2016 Apr; 7(17):24228-41. PubMed ID: 27015118
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin for aging stem cells.
Hambright WS; Philippon MJ; Huard J
Aging (Albany NY); 2020 Aug; 12(15):15184-15185. PubMed ID: 32756013
[No Abstract] [Full Text] [Related]
32. Moringa oleifera stem extract protect skin keratinocytes against oxidative stress injury by enhancement of antioxidant defense systems and activation of PPARα.
Zhou Y; Yang W; Li Z; Luo D; Li W; Zhang Y; Wang X; Fang M; Chen Q; Jin X
Biomed Pharmacother; 2018 Nov; 107():44-53. PubMed ID: 30077837
[TBL] [Abstract][Full Text] [Related]
33. The mTOR-inhibitor Sirolimus decreases the cyclosporine-induced expression of the oncogene ATF3 in human keratinocytes.
Schaper-Gerhardt K; Walter A; Schmitz-Rode C; Satzger I; Gutzmer R
J Dermatol Sci; 2018 Nov; 92(2):172-180. PubMed ID: 30220530
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
35. Curcumin inhibits carcinogen and nicotine-induced Mammalian target of rapamycin pathway activation in head and neck squamous cell carcinoma.
Clark CA; McEachern MD; Shah SH; Rong Y; Rong X; Smelley CL; Caldito GC; Abreo FW; Nathan CO
Cancer Prev Res (Phila); 2010 Dec; 3(12):1586-95. PubMed ID: 20851953
[TBL] [Abstract][Full Text] [Related]
36. Rapamycin, proliferation and geroconversion to senescence.
Blagosklonny MV
Cell Cycle; 2018; 17(24):2655-2665. PubMed ID: 30541374
[TBL] [Abstract][Full Text] [Related]
37. RAD001 enhances the radiosensitivity of SCC4 oral cancer cells by inducing cell cycle arrest at the G2/M checkpoint.
Yu CC; Hung SK; Liao HF; Lee CC; Lin HY; Lai HC; Li SC; Ho HC; Huang HB; Su YC
Anticancer Res; 2014 Jun; 34(6):2927-35. PubMed ID: 24922656
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of mTOR by apigenin in UVB-irradiated keratinocytes: A new implication of skin cancer prevention.
Bridgeman BB; Wang P; Ye B; Pelling JC; Volpert OV; Tong X
Cell Signal; 2016 May; 28(5):460-468. PubMed ID: 26876613
[TBL] [Abstract][Full Text] [Related]
39. Dietary rapamycin supplementation reverses age-related vascular dysfunction and oxidative stress, while modulating nutrient-sensing, cell cycle, and senescence pathways.
Lesniewski LA; Seals DR; Walker AE; Henson GD; Blimline MW; Trott DW; Bosshardt GC; LaRocca TJ; Lawson BR; Zigler MC; Donato AJ
Aging Cell; 2017 Feb; 16(1):17-26. PubMed ID: 27660040
[TBL] [Abstract][Full Text] [Related]
40. Endothelial replicative senescence delayed by the inhibition of MTORC1 signaling involves MicroRNA-107.
Khor ES; Wong PF
Int J Biochem Cell Biol; 2018 Aug; 101():64-73. PubMed ID: 29857052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
